Pfizer ‘intensively researching’ long-lasting COVID-19 vaccine

Pfizer's CEO said the company is currently focused on developing a COVID-19 vaccine that offers protection for at least one year in anticipation that longer lasting efficacy will encourage more people to stay up to date with vaccine recommendations. 

Read the full post at Becker's Hospital Review - Healthcare News
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive